Abbott Laboratories (TSX:ABT)
Canada · Delayed Price · Currency is CAD 18.52
+0.32 (1.76%)
Oct 30, 2026, 3:49 PM EDT
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of CAD 256.41 billion as of October 30, 2026. Its market cap has decreased by 14.71% in one year.
Market Cap
256.41B
Enterprise Value
295.15B
Revenue
68.47B
Global Rank
n/a
Country Rank
n/a
PE Ratio
39.47
ChartMarket Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 256.41B, an increase of 40,197.58%. That is a compound annual growth rate of 10.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 256.41B | -14.16% |
| Dec 31, 2025 | 298.71B | 5.82% |
| Dec 31, 2024 | 282.28B | 11.86% |
| Dec 29, 2023 | 252.36B | -2.60% |
| Dec 30, 2022 | 259.08B | -15.18% |
| Dec 31, 2021 | 305.44B | 27.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vector Science and Therapeutics | 304.91M |
| Profound Medical | 299.93M |
| Theralase Technologies | 62.10M |
| Cannabix Technologies | 56.66M |
| Cheelcare | 27.50M |
| Perimeter Medical Imaging AI | 20.71M |
| Ventripoint Diagnostics | 15.43M |
| Conavi Medical | 15.18M |